How to promote the development of the biomedical industry in the pilot free trade zone?
FDA accelerates approval of the first CD19-targeted antibody conjugate drug has been clinically approved in China
The FDA today accelerated the approval of the first antibody conjugate drug targeting CD19, and it has been approved for clinical trials in China
[Ling Fuli La] May 1 Labor Day, "Diagnosis and Treatment of Chronic Digestive System Diseases" will be given as free shipping, limited to 100 copies!
The Department of Livestock Development of Thailand issued the Cage free Eggs certification mark
Br J Cancer: Body Mass Index (BMI) and Absolute Lymphocyte Count (ALC): Predictors of disease-free survival for breast cancer patients
Cansino: 13-valent pneumococcal polysaccharide conjugate vaccine enters phase III clinical trial
Self-supplier of solvent-free paint and paint in Guiyang, Guizhou-Keguan
2021 EBMT | TBF program can improve disease-free survival of AML patients in complete remission
Antibody-drug conjugate enfortumab vedotin prolongs survival of patients with metastatic urothelial carcinoma
Conference to Accelerate the Promotion of Free New Coronavirus Vaccination to Build an Immunity Barrier to Protect People's Health
conjugated new drug has completed the production site
Sign up for the Metz applet, 100 Metz points will be given for free, and there will be warm guns
"Barrier Free" Circulation in the Medical Union!
Brit J Cancer: Body mass index and absolute lymphocyte count can predict disease-free survival of breast cancer patients
Recently, the British Journal of Cancer, an authoritative journal in the field of oncology, published a research
Rewrite clinical practice: disease-free survival is doubled, and immune adjuvant therapy for esophageal cancer will become a new standard!
This "free air under the diaphragm" is not caused by gastrointestinal perforation. Don't be misdiagnosed.
Nearly a quarter of lung cancer patients are cancer-free after surgery!
Gilead's Trop-2 antibody conjugate drug gains second indication
Express | Gilead's Trop-2 antibody-conjugated drug gains second indication for the treatment of bladder cancer